David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
David Goodman
Chief Executive Officer
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
175
Since Nov 2021
205
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Cédrick Devedeux Delorme · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Mélanie Joly · Ministre de l'Industrie et ministre responsable pour le développement économique Canada pour les régions du Québec, Innovation, Science and Economic Development Canada (ISED)
Cédrick Devedeux Delorme · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Patrice Lepage · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Sean Letourneau · Directeur, Innovation, Science and Economic Development Canada (ISED)
Alhadji Mamat · Gestionnaire princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Éric Sabourin · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
and 1 more Show fewer
Catherine Martinelli · Analyste des risques opérationnels, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Laura Bourns · Directeur, Finance Canada (FIN)
Nadeen Abd El Aal · Analyste, Innovation, Science and Economic Development Canada (ISED)
Jimmy Lou · economiste, Finance Canada (FIN)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Mélanie Joly · Ministre de l'Industrie et ministre responsable pour le développement économique Canada pour les régions du Québec, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Caroline Ménard · Manager, Préparation aux crises sanitaires Canada, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Ritu Banerjee · Sous-ministre adjoint(e), Innovation, Science and Economic Development Canada (ISED)
Caroline Ménard · Manager, Préparation aux crises sanitaires Canada, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Arianne Reza · Deputy Minister, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Ritu Banerjee · Sous-ministre adjoint(e), Innovation, Science and Economic Development Canada (ISED)
Jocelyne Voisin · Sous-ministre adjointe principale, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Patrice Lepage · Analyste principal d'investissements, Innovation, Science and Economic Development Canada (ISED)
Sean Letourneau · Directeur, Innovation, Science and Economic Development Canada (ISED)
Alhadji Mamat · Gestionnaire princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Catherine Martinelli · Analyste des risques opérationnels, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Jocelyne Voisin · Sous-ministre adjointe principale, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Jacques Ramsay · Député
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Jean-Sébastien Côté · Gestionnaire de bureau, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Mélanie Joly · Ministre de l'Industrie et ministre responsable pour le développement économique Canada pour les régions du Québec, Innovation, Science and Economic Development Canada (ISED)
Jacques Ramsay · Député
Marjorie Michel · Ministre de la Santé, Health Canada (HC)
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
and 3 more Show fewer
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Justine Frame · Conseillère en politiques, Health Canada (HC)
Shalene Curtis-Micallef · Sous-ministre, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Robyn Brake · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Tanya Ramsamy · Directrice executive, Health Canada (HC)
Alysha Croker · Directrice, Health Canada (HC)
Christiane Grise-Bard · Directrice associée par intérim, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Miro Froehlich · Directeur des politiques, Privy Council Office (PCO)
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Isabelle Buchanan · Conseillère en politiques, Global Affairs Canada (GAC)
Jasmine Gill · Directrice des politiques, Global Affairs Canada (GAC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Erin Campbell · Directrice, Innovation, Science and Economic Development Canada (ISED)
Brad Jenkins · Conseiller expert en recherche et analyse des politique, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Miro Froehlich · Directeur des politiques, Privy Council Office (PCO)
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Jasmine Gill · Directrice des politiques, Global Affairs Canada (GAC)
Isabelle Buchanan · Conseillère en politiques, Global Affairs Canada (GAC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Miro Froehlich · Directeur des politiques, Privy Council Office (PCO)
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Isabelle Buchanan · Conseillère en politiques, Global Affairs Canada (GAC)
Jasmine Gill · Directrice des politiques, Global Affairs Canada (GAC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Erin Campbell · Directrice, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Page 1
Older →
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.